Key Points - Faruqi & Faruqi, LLP reminds investors of the October 27, 2026 deadline for the securities class action lawsuit against Hyliion Holdings Corp. - Hyliion investors who suffered losses urged to contact James (Josh) Wilson directly. - Multiple law firms, including Faruqi & Faruqi, LLP, are investigating potential claims against Hyliion. - Johnson...
Key Points - Rosen Law Firm reminds Capricor Therapeutics investors of September 28, 2026 lead plaintiff...
Key Points - Rosen Law Firm announces class action lawsuit on behalf of Flotek Industries, Inc....
Sportsman's Warehouse Holdings, Inc. (SPWH) - This analysis reviews how the stock price reacted after the...
Zepp Health Corporation (ZEPP) - This analysis reviews how the stock price reacted after the last...
Sean Milligan from Needham issued a price target of $20.00 for BW on 2026-08-31 10:57:16.The adjusted price target was set to $20.00.At the time of the announcement, BW was trading...
Raghuram Selvaraju from H.C. Wainwright issued a price target of $19.00 for BWAY on 2026-08-31 10:06:39.The adjusted price target was set to $19.00.At the time of the announcement, BWAY was...
Ryan Meyers from Lake Street issued a price target of $6.00 for LFVN on 2026-08-28 12:51:29.The adjusted price target was set to $6.00.At the time of the announcement, LFVN was...
from Ascendiant issued a price target of $5.00 for GNSS on 2026-08-28 10:53:37.The adjusted price target was set to $5.00.At the time of the announcement, GNSS was trading at $1.55.The...
from CLSA issued a price target of $3.80 for BZUN on 2026-08-28 08:45:48.The adjusted price target was set to $3.80.At the time of the announcement, BZUN was trading at $3.02.The...
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
